Targeting mTOR and Src restricts hepatocellular carcinoma growth in a novel murine liver cancer model

PloS One
Sarah WalkerLionel Hebbard

Abstract

Liver cancer is a poor prognosis cancer with limited treatment options. To develop a new therapeutic approach, we derived HCC cells from a known model of murine hepatocellular carcinoma (HCC). We treated adiponectin (APN) knock-out mice with the carcinogen diethylnitrosamine, and the resulting tumors were 7-fold larger than wild-type controls. Tumors were disassociated from both genotypes and their growth characteristics evaluated. A52 cells from APN KO mice had the most robust growth in vitro and in vivo, and presented with pathology similar to the parental tumor. All primary tumors and cell lines exhibited activity of the mammalian target of Rapamycin (mTOR) and Src pathways. Subsequent combinatorial treatment, with the mTOR inhibitor Rapamycin and the Src inhibitor Dasatinib reduced A52 HCC growth 29-fold in vivo. Through protein and histological analyzes we observed activation of these pathways in human HCC, suggesting that targeting both mTOR and Src may be a novel approach for the treatment of HCC.

References

Jun 18, 2002·Nature Medicine·Norikazu MaedaYuji Matsuzawa
Feb 26, 2003·The Journal of Biological Chemistry·Tianyun Jiang, Yun Qiu
Apr 25, 2003·The New England Journal of Medicine·Eugenia E CalleMichael J Thun
Jul 9, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jason M HuiJacob George
Apr 28, 2006·The FEBS Journal·Heike RebholzIvan T Gout
Feb 20, 2008·Neoplasia : an International Journal for Oncology Research·Martina VojtechováZdena Tuhácková
Jul 25, 2008·The New England Journal of Medicine·Josep M LlovetUNKNOWN SHARP Investigators Study Group
Oct 22, 2008·Gastroenterology·Augusto VillanuevaJosep M Llovet
Nov 26, 2008·World Journal of Gastroenterology : WJG·Tamao NishiharaIichiro Shimomura
Dec 31, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Valérie ParadisJacques Belghiti
May 19, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Martin S DenzelBarbara Ranscht
Jul 4, 2009·Cancer Cell·Xiang H-F ZhangJoan Massagué
Oct 1, 2009·Journal of Gastroenterology and Hepatology·Takeharu AsanoShin Ohnishi
Jun 8, 2010·Clinical Science·Maria Luisa BalmerJean-François Dufour
Sep 8, 2010·Oncogene·L HebbardR G Oshima
Dec 2, 2010·Nature Reviews. Gastroenterology & Hepatology·Lionel Hebbard, Jacob George
Dec 4, 2010·International Journal of Cancer. Journal International Du Cancer·Judith ErtleAli Canbay
Feb 19, 2013·Oncogene·L N Kwong, M A Davies
Sep 18, 2013·Nature Reviews. Gastroenterology & Hepatology·Rohit Loomba, Arun J Sanyal
Sep 21, 2013·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Ta-Chiang LiuElizabeth M Brunt
Nov 5, 2013·Nature Reviews. Gastroenterology & Hepatology·Katrina Ray
Dec 7, 2013·Journal of Hepatology·Matthias S MatterSnorri S Thorgeirsson
Jan 15, 2014·Best Practice & Research. Clinical Endocrinology & Metabolism·Lionel Hebbard, Barbara Ranscht
Feb 14, 2014·Cancer Metastasis Reviews·Andreas VarkarisPaul G Corn
Jul 25, 2014·JAMA : the Journal of the American Medical Association·Andrew X ZhuLi-Tzong Chen
Sep 16, 2014·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayFreddie Bray
Jan 13, 2015·The Journal of Biological Chemistry·Mehdi Ramezani-MoghadamLionel Hebbard
Feb 18, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D KoeberleUNKNOWN Swiss Group for Clinical Cancer Research (SAKK)
May 24, 2016·International Journal of Molecular Sciences·Luis Calzadilla Bertot, Leon Anton Adams

❮ Previous
Next ❯

Citations

Jan 28, 2020·International Journal of Molecular Medicine·Zhaoyun LiuRong Fu
Sep 11, 2020·Biomedicines·Chin-King LooiChun-Wai Mai
Oct 9, 2020·Scientific Reports·Brittany DewdneyLionel Hebbard
Apr 4, 2021·International Journal of Molecular Sciences·Bingting YuMaikel P Peppelenbosch

❮ Previous
Next ❯

Methods Mentioned

BETA
FCS
ELISA
biopsies

Software Mentioned

Photoshop
Graphpad Prism
ImageJ

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.